Brooklyn Investment Group Sells 342 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Brooklyn Investment Group lowered its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 5.5% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 5,870 shares of the healthcare conglomerate’s stock after selling 342 shares during the quarter. UnitedHealth Group accounts for 0.9% of Brooklyn Investment Group’s portfolio, making the stock its 20th biggest position. Brooklyn Investment Group’s holdings in UnitedHealth Group were worth $2,969,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also recently bought and sold shares of the company. Whitener Capital Management Inc. boosted its holdings in UnitedHealth Group by 2.3% during the fourth quarter. Whitener Capital Management Inc. now owns 5,884 shares of the healthcare conglomerate’s stock worth $2,976,000 after purchasing an additional 130 shares during the last quarter. Somerset Trust Co grew its holdings in shares of UnitedHealth Group by 4.9% in the fourth quarter. Somerset Trust Co now owns 6,573 shares of the healthcare conglomerate’s stock valued at $3,325,000 after acquiring an additional 310 shares in the last quarter. Merit Financial Group LLC boosted its position in UnitedHealth Group by 72.2% in the fourth quarter. Merit Financial Group LLC now owns 14,789 shares of the healthcare conglomerate’s stock worth $7,481,000 after purchasing an additional 6,202 shares during the last quarter. Chemistry Wealth Management LLC raised its stake in shares of UnitedHealth Group by 0.8% during the 4th quarter. Chemistry Wealth Management LLC now owns 7,609 shares of the healthcare conglomerate’s stock worth $3,849,000 after purchasing an additional 61 shares during the period. Finally, CNB Bank increased its holdings in UnitedHealth Group by 3.7% during the fourth quarter. CNB Bank now owns 4,870 shares of the healthcare conglomerate’s stock worth $2,464,000 after buying an additional 173 shares during the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Trading Down 0.1 %

NYSE UNH opened at $510.03 on Friday. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73. The stock has a 50-day moving average of $551.50 and a 200-day moving average of $562.62. The firm has a market cap of $469.37 billion, a PE ratio of 33.23, a price-to-earnings-growth ratio of 1.42 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. The company had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The firm’s revenue was up 6.8% compared to the same quarter last year. During the same period in the prior year, the business posted $5.83 EPS. As a group, sell-side analysts forecast that UnitedHealth Group Incorporated will post 27.6 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, December 17th. Investors of record on Monday, December 9th were paid a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 1.65%. The ex-dividend date of this dividend was Monday, December 9th. UnitedHealth Group’s payout ratio is currently 54.72%.

Analyst Upgrades and Downgrades

Several brokerages have recently issued reports on UNH. TD Cowen raised their price target on shares of UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a research note on Friday, October 18th. Bank of America cut their price target on UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a research note on Wednesday, October 16th. Oppenheimer upped their price objective on shares of UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a report on Friday, December 6th. KeyCorp restated an “overweight” rating and set a $650.00 price target on shares of UnitedHealth Group in a research note on Friday. Finally, StockNews.com downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Wednesday. Two investment analysts have rated the stock with a hold rating, nineteen have issued a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Buy” and a consensus price target of $627.74.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.